Overview

Project CLEAR - Changing Lives by Eradicating Antibiotic Resistance

Status:
Completed
Trial end date:
2019-01-01
Target enrollment:
Participant gender:
Summary
This randomized controlled trial will compare strategies to reduce the risk of methicillin-resistant Staphylococcus aureus (MRSA) infection and re-hospitalization in MRSA carriers. This trial will provide critical answers about the role of decolonization versus standard-of-care education in preventing MRSA infections in the large group of high risk MRSA-positive patients being discharged from hospitals. Findings could potentially impact best practice for the 1.8 million MRSA carriers who are discharged from US hospitals each year.
Phase:
N/A
Details
Lead Sponsor:
University of California, Irvine
Collaborator:
Agency for Healthcare Research and Quality (AHRQ)
Treatments:
Anti-Bacterial Agents